Malignant neoplasm of unspecified renal pelvis
ICD-10 C65.9 is a billable code used to indicate a diagnosis of malignant neoplasm of unspecified renal pelvis.
C65.9 refers to a malignant neoplasm located in the renal pelvis, which is the area of the kidney where urine collects before moving to the ureter. This type of cancer is part of the broader category of urinary tract malignancies, which can include cancers of the bladder, ureters, and kidneys. The renal pelvis is a less common site for malignancy compared to the bladder and renal parenchyma. Symptoms may include hematuria (blood in urine), flank pain, and urinary obstruction. Diagnosis typically involves imaging studies such as CT scans or MRIs, and confirmation is achieved through biopsy. Staging of renal pelvis cancer follows the TNM system, assessing tumor size (T), lymph node involvement (N), and metastasis (M). Treatment options may include surgical resection, such as nephroureterectomy, chemotherapy, and radiation therapy, depending on the stage and grade of the tumor. Accurate coding is essential for proper treatment planning and reimbursement.
Detailed imaging reports, biopsy results, and surgical notes.
Diagnosis and management of renal pelvis tumors, staging evaluations, and surgical interventions.
Ensure clear documentation of tumor size, location, and any metastasis for accurate coding.
Pathology reports, treatment plans, and follow-up care notes.
Chemotherapy administration, radiation therapy planning, and post-operative care.
Documenting the response to treatment and any changes in staging is crucial for accurate coding.
Used when a patient with C65.9 undergoes surgical resection of the affected kidney and ureter.
Operative reports detailing the procedure and findings.
Urology specialists must ensure accurate documentation of tumor characteristics.
Coding C65.9 is crucial for accurately representing a patient's diagnosis of malignant neoplasm in the renal pelvis, which impacts treatment decisions and reimbursement.
